Progressive Supranuclear Palsy Phase 2 Platform Clinical Trial Announces the Selection of AADvac1 and AZP2006 for its First Two Regimens
Accesswire
*LONDON, GB / ACCESS Newswire / April 28, 2025 / *The Progressive Supranuclear Palsy (PSP) Trial Platform (PTP), led by Drs. Adam..